Our Products
Loans
Cards
Insurance
Investment
Stock Market
Electronics Mall
CIBIL Score
Knowledge Centre
Academy 
Calculators
Our Services
My Account
Do not call
En
Nippon India Nifty Pharma ETF Share Price
Day's Range
Day's Range
Low
₹24.24
High
₹25.36
Price Summary
| Previous Close | ₹24.77 |
|---|---|
| Day's Range | ₹24.24 - ₹25.36 |
| Open | ₹25.36 |
| 52 Week Range | N/A - N/A |
| Volume | 1,42,60,951 |
| Market Cap |
Stocks Summary
| Trade Value ( ₹ in Lacs) | 3,532.44 |
|---|---|
| Market Cap (₹ in Mn) | |
| Dividend Yield(%) | |
| Price/Earning (TTM) | |
| TTM EPS (₹) | |
| P/E Ratio | |
| Book Value(₹) | |
| PAT Margin (%) | |
| Face Value (₹) | |
| ROCE(%) |
About Nippon India Nifty Pharma ETF
| NSE Symbol | PHARMABEES |
|---|
Peer Comparision
| Stocks Name | Market Cap (Cr)(₹) | Market Price (₹) | 52 Week Low-High (₹) |
|---|
No Records Found
Latest News
Paradeep Parivahan informs about press release
Home First Finance Company India informs about allotment of ESOP
Glenmark Pharmaceuticals informs about press release
Glenmark Pharmaceuticals has informed that, Glenmark Pharmaceuticals Inc., USA (Glenmark) today announced the launch of Methylene Blue Injection USP, 50 mg/10 mL (5 mg/mL) Single‐Dose Vial. Glenmark’s Methylene Blue Injection USP is bioequivalent and therapeutically equivalent to the reference listed drug, ProvayBlue® Injection, 50 mg/10 mL (5 mg/mL), of Provepharm SAS [NDA 204630]. According to IQVIA® sales data for the 12‐month period ending April 2026, the ProvayBlue® Injection, 50 mg/10 mL (5 mg/mL) market achieved annual sales of approximately $19.0 million. The company has attached media release.
3The above information is a part of company’s filings submitted to BSE.
Coforge informs about grant of options under ESOP
FIIs were net sellers of Rs 37124.42 crore in index futures and options segments on June 16
According to the data released by the NSE, the Foreign Institutional Investors (FIIs) were net sellers of Rs 37124.42 crore in index futures and options segments, as per Tuesday’s data, June 16, 2026.
FIIs were net buyers of index futures to the tune of Rs 1782.81 crore and net sellers of index options worth Rs 38907.23 crore. In the stock segment, FII’s were net sellers of stock futures worth Rs 1727.43 crore and they sold stock options worth Rs 32.45 crore.
No Records Found
Sign in to Unlock Offers!
We don't SPAM
Frequently Asked Questions
The current share price of Nippon India Nifty Pharma ETF is ₹24.77 as of 2026-06-17.
The market capitalisation of Nippon India Nifty Pharma ETF is ₹ as of .
The 1-year return of Nippon India Nifty Pharma ETF is -0.03% as of 2026-06-17.
The P/E ratio of Nippon India Nifty Pharma ETF is as of .
The 52-week high and low of Nippon India Nifty Pharma ETF are ₹ and ₹, respectively, as of 2026-06-17.
Disclaimer
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.
